Early detection of progressive chronic kidney disease: Is it feasible?

被引:25
作者
Gansevoort, Ron T.
Bakker, Stephan J. L.
De Jong, Paul E.
机构
[1] Univ Hosp Groningen, Div Internal Med & Nephrol, NL-9713 Groningen, Netherlands
[2] Univ Groningen, Div Nephrol, Groningen, Netherlands
[3] Univ Groningen, Dept Internal Med, Groningen, Netherlands
[4] Univ Groningen, Ctr Med, Groningen, Netherlands
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 05期
关键词
D O I
10.1681/ASN.2006030247
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1218 / 1220
页数:3
相关论文
共 19 条
[1]  
[Anonymous], DIABETES CARE, DOI DOI 10.2337/DIACARE.25.2007.S85
[2]   Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria [J].
Asselbergs, FW ;
Diercks, GFH ;
Hillege, HL ;
van Boven, AJ ;
Janssen, WMT ;
Voors, AA ;
de Zeeuw, D ;
de Jong, PE ;
van Veldhuisen, DJ ;
van Gilst, WH .
CIRCULATION, 2004, 110 (18) :2809-2816
[3]   Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of REnal and vascular ENdstage disease (PREVEND) study and the prevention of REnal and vascular ENdstage disease intervention trial (PREVEND IT) [J].
Atthobari, J ;
Asselbergs, FW ;
Boersma, C ;
de Vries, R ;
Hillege, HL ;
van Gilst, WH ;
Gansevoort, RT ;
de Jong, PE ;
de Jong-van den Berg, LTW ;
Postma, MJ .
CLINICAL THERAPEUTICS, 2006, 28 (03) :432-444
[4]   Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension [J].
Bigazzi, R ;
Bianchi, S ;
Baldari, D ;
Campese, VM .
JOURNAL OF HYPERTENSION, 1998, 16 (09) :1325-1333
[5]   Screening for proteinuria in US adults - A cost-effectiveness analysis [J].
Boulware, LE ;
Jaar, BG ;
Tarver-Carr, ME ;
Brancati, FL ;
Powe, NR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23) :3101-3114
[6]   The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population [J].
Gansevoort, RT ;
Verhave, JC ;
Hillege, HL ;
Burgerhof, JGM ;
Bakker, SJL ;
de Zeeuw, D ;
de Jong, PE .
KIDNEY INTERNATIONAL, 2005, 67 :S28-S35
[7]   Trends in the incidence of treated end-stage renal failure in The Netherlands: Hope for the future? [J].
Gansevoort, RT ;
van der Heij, B ;
Stegeman, CA ;
de Charro, FT ;
Nieuwenhuizen, MG ;
de Zeeuw, D ;
de Jong, PE .
KIDNEY INTERNATIONAL, 2004, 66 :S7-S10
[8]   Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population [J].
Hillege, HL ;
Fidler, V ;
Diercks, GFH ;
van Gilst, WH ;
de Zeeuw, D ;
van Veldhuisen, DJ ;
Gans, ROB ;
Janssen, WMT ;
Grobbee, DE ;
de Jong, PE .
CIRCULATION, 2002, 106 (14) :1777-1782
[9]   Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy?: A LIFE substudy [J].
Ibsen, H ;
Wachtell, K ;
Olsen, MH ;
Borch-Johnsen, K ;
Lindholm, LH ;
Mogensen, CE ;
Dahlöf, B ;
Devereux, RB ;
de Faire, U ;
Fyhrquist, F ;
Julius, S ;
Kjeldsen, SE ;
Lederballe-Pedersen, O ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wan, Y .
JOURNAL OF HYPERTENSION, 2004, 22 (09) :1805-1811
[10]  
Iseki K, 2004, AM J KIDNEY DIS, V44, P806, DOI 10.1016/S0272-6386(04)01080-7